Michael Kelliher

Directeur/Membre du Conseil chez CAPRICOR THERAPEUTICS, INC.

Fortune : 1 M $ au 31/05/2024

47 ans

Health Technology

Consumer Services

Postes actifs de Michael Kelliher

Sociétés	Poste	Début	Fin
CAPRICOR THERAPEUTICS, INC.	Directeur/Membre du Conseil	01/09/2023	-
CAPRICOR THERAPEUTICS, INC.	Independent Dir/Board Member	01/09/2023	-
ARDELYX, INC.	Corporate Officer/Principal	25/03/2024	-

Sociétés	Poste	Début	Fin
HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY	Corporate Officer/Principal	01/01/2014	-

University College Cork

Undergraduate Degree

Internationale

Etats-Unis	3
Irlande	3

Opérationnelle

Corporate Officer/Principal	2
Director/Board Member	1
Independent Dir/Board Member	1

Sectorielle

Health Technology	4
Consumer Services	2

Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Sociétés cotées	2
CAPRICOR THERAPEUTICS, INC.	Health Technology
ARDELYX, INC.	Health Technology

Entreprise privées	1
Horizon Therapeutics Plc Horizon Therapeutics Plc Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Plc is a biopharmaceutical company, which engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Inflammation segments. The Orphan segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland.	Health Technology

Entreprise privées

Health Technology